2024
Polypharmacy in elective lumbar spinal surgery for degenerative conditions with 24-month follow-up
Dietz N, Kumar C, Elsamadicy A, Bjurström M, Wong K, Jamieson A, Sharma M, Wang D, Ugiliweneza B, Drazin D, Boakye M. Polypharmacy in elective lumbar spinal surgery for degenerative conditions with 24-month follow-up. Scientific Reports 2024, 14: 25340. PMID: 39455709, PMCID: PMC11511981, DOI: 10.1038/s41598-024-76248-6.Peer-Reviewed Original ResearchConceptsDegenerative lumbar pathologySurgical site infectionSpinal surgeryPolypharmacy groupSite infectionLumbar pathologyFollow-upMedical complicationsElective lumbar spinal surgeryLumbar spinal surgeryUrinary tract infectionDegenerative lumbar conditionsReturn to the emergency departmentTract infectionsNon-polypharmacy groupSurgical patientsLumbar conditionsSurgeryPatientsComplicationsPolypharmacyEmergency departmentPrescribed medicationsMarketScan datasetDegenerative conditions
2018
Minimally Invasive Lateral Access Surgery and Reoperation Rates: A Multi-Institution Retrospective Review of 2060 Patients
Nayar G, Wang T, Sankey EW, Berry-Candelario J, Elsamadicy AA, Back A, Karikari I, Isaacs R. Minimally Invasive Lateral Access Surgery and Reoperation Rates: A Multi-Institution Retrospective Review of 2060 Patients. World Neurosurgery 2018, 116: e744-e749. PMID: 29787875, DOI: 10.1016/j.wneu.2018.05.082.Peer-Reviewed Original ResearchConceptsRate of reoperationLateral access surgeryLumbar spine surgeryMore comorbiditiesSurgical approachSpine surgeryDecompressive lumbar spine surgeryElective lumbar spinal surgeryMulti-institution retrospective reviewAccess surgeryLower body mass indexLumbar spinal surgeryBody mass indexOpen posterior approachHealth care systemOnly significant predictorAdditional readmissionsLT cohortOP cohortOP surgeryReoperation ratePatient demographicsSurgical complicationsRetrospective reviewMass index